For: | Li W, Li CB. Lack of inhibitory effects of Lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rats. World J Gastroenterol 2003; 9(11): 2469-2473 [PMID: 14606078 DOI: 10.3748/wjg.v9.i11.2469] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2469.htm |
Number | Citing Articles |
1 |
Maria Pufulete. Intake of dairy products and risk of colorectal neoplasia. Nutrition Research Reviews 2008; 21(1): 56 doi: 10.1017/S0954422408035920
|
2 |
Daniel Commane, Roisin Hughes, Colette Shortt, Ian Rowland. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2005; 591(1-2): 276 doi: 10.1016/j.mrfmmm.2005.02.027
|
3 |
M. Andrea Azcárate-Peril, Michael Sikes, José M. Bruno-Bárcena. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(3): G401 doi: 10.1152/ajpgi.00110.2011
|
4 |
Amy C. Brown, Jonathan E. Reitzenstein, Jessie Liu, Martin R. Jadus. The anti-cancer effects of poi(Colocasia esculenta) on colonic adenocarcinoma cellsIn vitro. Phytotherapy Research 2005; 19(9): 767 doi: 10.1002/ptr.1712
|
5 |
Shinji Kobuchi, Yukako Ito, Kae Okada, Kazuki Imoto, Shota Kuwano, Kanji Takada. Pharmacokinetic/Pharmacodynamic Modeling of 5-Fluorouracil by Using a Biomarker to Predict Tumor Growth in a Rat Model of Colorectal Cancer. Journal of Pharmaceutical Sciences 2013; 102(6): 2056 doi: 10.1002/jps.23547
|
6 |
Derek V. Seidel, M. Andrea Azcárate-Peril, Robert S. Chapkin, Nancy D. Turner. Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk. Seminars in Cancer Biology 2017; 46: 191 doi: 10.1016/j.semcancer.2017.06.009
|
7 |
Jing Zhang, Piyun Zhang, Sijia Li, Ting Yu, Xiangyu Lai, Yongpeng He. Study on the effect and mechanism of Lacticaseibacillus rhamnosus AFY06 on inflammation-associated colorectal cancer induced by AOM/DSS in mice. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1382781
|
8 |
Shinji Kobuchi, Yukako Ito, Kae Okada, Kazuki Imoto, Kanji Takada. Pharmacokinetics of 5-fluorouracil and increased hepatic dihydropyrimidine dehydrogenase activity levels in 1,2-dimethylhydrazine-induced colorectal cancer model rats. European Journal of Drug Metabolism and Pharmacokinetics 2013; 38(3): 171 doi: 10.1007/s13318-012-0114-9
|
9 |
Shinji Kobuchi, Shota Kuwano, Kazuki Imoto, Kae Okada, Asako Nishimura, Yukako Ito, Nobuhito Shibata, Kanji Takada. A predictive biomarker for altered 5‐fluorouracil pharmacokinetics following repeated administration in a rat model of colorectal cancer. Biopharmaceutics & Drug Disposition 2013; 34(7): 365 doi: 10.1002/bdd.1851
|
10 |
Ravinder Nagpal, Ashwani Kumar, Manoj Kumar, Pradip V. Behare, Shalini Jain, Hariom Yadav. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiology Letters 2012; 334(1): 1 doi: 10.1111/j.1574-6968.2012.02593.x
|
11 |
Katarzyna Garbacz. Anticancer activity of lactic acid bacteria. Seminars in Cancer Biology 2022; 86: 356 doi: 10.1016/j.semcancer.2021.12.013
|
12 |
Kuntal Ganguly, Anandrao R. Kulkarni, Tejraj M. Aminabhavi. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats. Drug Delivery 2016; 23(8): 2838 doi: 10.3109/10717544.2015.1105324
|
13 |
Mehran Mahooti, Elahe Abdolalipour, Samira Sanami, Davood Zare. Inflammatory Modulation Effects of Probiotics: A Safe and Promising Modulator for Cancer Prevention. Current Microbiology 2024; 81(11) doi: 10.1007/s00284-024-03901-8
|
14 |
Gabriele Capurso, Massimo Marignani, Gianfranco Delle Fave. Probiotics and the incidence of colorectal cancer: when evidence is not evident. Digestive and Liver Disease 2006; 38: S277 doi: 10.1016/S1590-8658(07)60010-3
|
15 |
Ziyaur Rahman, Kanchan Kohli, Shuang-Qing Zhang, Roop K Khar, Mushir Ali, Naseem A Charoo, Mohammad Tauseef, Areeg A A Shamsher, Noorullah N Mohammed, Michael A Repka. In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. Journal of Pharmacy and Pharmacology 2008; 60(5): 615 doi: 10.1211/jpp.60.5.0007
|
16 |
Kuntal Ganguly, Anandrao R. Kulkarni, Tejraj M. Aminabhavi. In vitrocytotoxicity andin vivoefficacy of 5-fluorouracil-loaded enteric-coated PEG-crosslinked chitosan microspheres in colorectal cancer therapy in rats. Drug Delivery 2015; : 1 doi: 10.3109/10717544.2015.1089955
|
17 |
K. Sivieri, A. L. T. Spinardi-Barbisan, L. F. Barbisan, R. Bedani, N. D. Pauly, I. Z. Carlos, F. Benzatti, R. C. Vendramini, E. A. Rossi. Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. European Food Research and Technology 2008; 228(2): 231 doi: 10.1007/s00217-008-0927-6
|
18 |
Ran Liu, Ran Ma, Chunyu Yu, Cathy Wenchuan Bi, Yidi Yin, Huarong Xu, Hongwei Shang, Kaishun Bi, Qing Li. Quantitation of eleven active compounds of Aidi injection in rat plasma and its application to comparative pharmacokinetic study. Journal of Chromatography B 2016; 1026: 105 doi: 10.1016/j.jchromb.2015.07.059
|
19 |
Philip Allsopp, Ian Rowland. Prebiotics and Probiotics Science and Technology. 2009; : 997 doi: 10.1007/978-0-387-79058-9_26
|
20 |
Kiran Chaturvedi, Santosh Kumar Tripathi, Anandrao R. Kulkarni, Tejraj M. Aminabhavi. Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres. Journal of Microencapsulation 2013; 30(4): 356 doi: 10.3109/02652048.2012.735263
|
21 |
Probiotics and Human Health: An Overview. Journal of Nutrition Food Science and Technology 2023; doi: 10.47485/2834-7854.1025
|